Related Experiment Video
Updated: May 24, 2026
12:08
Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
Published on: November 15, 2024
The human IL-7 receptor gene: deletions, polymorphisms and mutations
Renata I Mazzucchelli1, Agostino Riva, Scott K Durum
1Laboratory of Gene Therapy and Primary Immunodeficiency, San Raffaele Telethon Institute for Gene Therapy, Milan, Italy.
Seminars in Immunology
|March 20, 2012
Summary
Interleukin-7 receptor (IL-7R) signaling is crucial for T cell survival. Genetic variations in IL-7R are linked to numerous immune and autoimmune diseases, suggesting targeted therapies.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Interleukin-7 (IL-7) is essential for the survival of most T cell subsets.
- IL-7 initiates signaling by binding to IL-7 receptor alpha (IL-7Rα) and common gamma chain (γc).
- IL-7Rα deficiency causes severe combined immunodeficiency in humans.
Purpose of the Study:
- To investigate the role of IL-7R polymorphisms in immune and inflammatory diseases.
- To identify specific IL-7R variants associated with disease risk.
- To explore the therapeutic potential of targeting the IL-7 pathway.
Main Methods:
- Analysis of IL-7R gene polymorphisms.
- Association studies with various autoimmune and inflammatory conditions.
- Investigation of IL-7R gain-of-function mutations in leukemia.
Main Results:
- IL-7R polymorphisms are risk factors for multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and other immune-related diseases.
- The T244I polymorphism is specifically associated with increased risk for many of these immunopathologies.
- Gain-of-function mutations in the IL-7R T244I region are implicated in acute lymphoblastic leukemia.
Conclusions:
- The IL-7 pathway, particularly the IL-7R, plays a significant role in immune homeostasis and disease pathogenesis.
- Specific IL-7R polymorphisms represent key genetic risk factors for a spectrum of immune-mediated disorders.
- Targeting the IL-7 pathway offers a promising therapeutic strategy for these conditions.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...